Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Q32022
Sort By
Newest First
1 / 2
1 / 2
Viral Vectors
Risk-Based Optimization of Viral Vector Processes Adds Real Value
Elie Hanania, Ph.D.; Tatiana Mello, M.S.
Avid Bioservices
PAO-09-022-CL-05
October 25, 2022
Antibiotic Resistance
Antibiotic Resistance: Advances in Understanding and Drug Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-10-022-NI-07
October 11, 2022
Column: New Drug Watch
Potential Applications for Antisense Oligonucleotide Therapies Continue to Expand
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-10-022-NI-06
October 11, 2022
Cell and Gene Therapy
State of the Cell and Gene Therapy Market
James Grote
Nice Insight
PAO-10-022-NI-01
October 11, 2022
mRNA
Limitless Potential of mRNA Creates Tremendous Excitement Despite Uncertainties
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-10-022-NI-02
October 11, 2022
Precision Medicine
Examining the Potential of Precision/Personalized Medicine
David Alvaro, Ph.D.
Pharma's Almanac
PAO-10-022-NI-03
October 11, 2022
Column: Supply Chain
Reimagining the Pharmaceutical Supply Chain
Danielle Alvarez
Pharma's Almanac
PAO-10-022-NI-04
October 11, 2022
Big Data
Leveraging Big Data, Artificial Intelligence, and Machine Learning for Drug Discovery, Development, Manufacturing, and More
Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.
Pharma's Almanac
PAO-10-022-NI-05
October 11, 2022
Future of the Industry
What key indicators do you look at to predict the future of this industry?
Pharma's Almanac
PAO-10-022--RT-02
October 11, 2022
Sustainability
What is your plan to build a more sustainable business practice in the coming years?
Pharma's Almanac
PAO-10-022--RT-01
October 11, 2022
Transient Expression
Overcoming Limitations with Transient Protein Expression to Accelerate Development
Cenk Sumen, Ph.D.
MaxCyte
PAO-10-022-CL-02
October 11, 2022
Clinical Workflow Integration
How All Clinical Trial Stakeholders Can Collaborate as One Study Team
OneStudyTeam
PAO-10-022-CL-01
October 10, 2022
European DCTs
Exploring Challenges and Considerations for Operationalizing DCTs in the European Union
Kamilla Posselt
PPD, part of Thermo Fisher Scientific
PAO-09-022-CL-07
October 06, 2022
Real-Time Monitoring
Raman Spectroscopy as a PAT Tool Advancing Biopharma Manufacturing
Stacy Shollenberger
MilliporeSigma
PAO-09-022-CL-08
September 30, 2022
Digital Health Solutions
Beyond Drug Sales: Adding Value with Digital Health
Gérard Klop; Marcos Gallego Llorente, Ph.D.
PAO-08-022-CL-05
September 28, 2022
Neurodegenerative Disease Clinical Trials
Preparing for Growth in Neurodegenerative Treatment Opportunities: How Clinical Teams can Best Position Study Design and Strategy to Reach Study Participants
John Hamlet; Christine Martino, MPM; Sabine Krofczik-Wilhelm, Ph.D.; Alberto Lledó, M.D., Ph.D.
PPD, part of Thermo Fisher Scientific
PAO-09-022-CL-09
September 27, 2022
Clinical Trials Adherence
Evolving Solutions to Optimize Clinical Trial Decentralization
Tim Rich; John Musaus
PPD, part of Thermo Fisher Scientific
PAO-09-022-CL-06
September 24, 2022
Speed to Clinic
Leveraging Experience to Reduce Timelines for IND-Enabling Activities
Muctarr Sesay, Ph.D.; Andrew Majdoch, M.Sc.
GBI
PAO-09-022-CL-04
September 19, 2022
Biodefense
Supporting Biodefense Countermeasures with Strong Capabilities and Expertise
Brian O’Mara
Scorpius BioManufacturing
PAO-09-022-CL-03
September 19, 2022
CDMO
Asymchem: Leading with Technology
Asymchem
PAO-09-022-CL-01
September 13, 2022
